Results 31 to 40 of about 69,058 (290)

Stratégie d’émission des titres publics par le trésor congolais de 2019 à 2023 [PDF]

Mouvements et Enjeux Sociaux, 2023
La qualité d’exécution des dépenses publiques par le Trésor est étroitement liée à la manière dont les ressources sont mobilisées. Plusieurs sources permettent à un Etat de lever les fonds publics pour réaliser ses objectifs ; d’une part, la fiscalité ...
Danny BAPEBABO ILUNGA
doaj  

Brute Force Composition Scanning with a CALPHAD Database to Find Low Temperature Body Centered Cubic High Entropy Alloys

Entropy, 2018
We used the Thermo-Calc High Entropy Alloy CALPHAD database to determine the stable phases of AlCrMnNbTiV, AlCrMoNbTiV, AlCrFeTiV and AlCrMnMoTi alloys from 800 to 2800 K. The concentrations of elements were varied from 1⁻49 atom%.
T. P. C. Klaver, D. Simonovic, M. H. F. Sluiter   +2 more
doaj   +1 more source

Seville-BCC-CSM1.1-RCP8.5

, 2015
Downscaled (bias-corrected) daily temperature data (150 simulations for 10 years) based on the BCC-CSM1.1 CMIP5 model. Seville station Spain.
Efrat Morin (3296838), Shai Morin (477123), Royi Zidon (3296841), Hirotsugu Tsueda (3296844)   +3 more
core   +1 more source

Diagnostic Value of Optical Coherence Tomography Image Features for Diagnosis of Basal Cell Carcinoma

Acta Dermato-Venereologica, 2021
Optical coherence tomography (OCT) is a non-invasive diagnostic method. Numerous morphological OCT features have been described for diagnosis of basal cell carcinoma (BCC).
Fieke Adan, Klara Mosterd, Nicole W.J. Kelleners-Smeets, Patty J. Nelemans   +3 more
doaj   +1 more source

Seville-BCC-CSM1.1-Current

, 2015
Downscaled (bias-corrected) daily temperature data (150 simulations for 10 years) based on the BCC-CSM1.1 CMIP5 model. Seville station Spain.
Morin, Efrat, Zidon, Royi, Morin, Shai, Efrat Morin (3296838), Shai Morin (477123), Royi Zidon (3296841), Hirotsugu Tsueda (3296844), Tsueda, Hirotsugu   +7 more
core   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

Molecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober, Leire Moreno‐Cugnon, Laura Martínez‐Pérez, Amaia Ercilla, Amaia Zabala‐Letona, Adrián Vicente‐Barrueco, Maider Fagoaga‐Eugui, Saioa Garcia‐Longarte, Blanca Calle‐Ciborro, Encarnación Pérez‐Andrés, Onintza Carlevaris, Sara Pozo, Isabel Mendizabal, Ugo Mayor, Arkaitz Carracedo, Violaine Sée, Edurne Berra   +16 more
wiley   +1 more source

BeitJamal-BCC-CSM1.1-Current

, 2015
Downscaled (bias-corrected) daily temperature data (150 simulations for 10 years) based on the BCC-CSM1.1 CMIP5 model. Beit-Jamal station Israel.
Morin, Efrat, Zidon, Royi, Morin, Shai, Efrat Morin (3296838), Shai Morin (477123), Royi Zidon (3296841), Hirotsugu Tsueda (3296844), Tsueda, Hirotsugu   +7 more
core   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Seville-BCC-CSM1.1-RCP4.5

, 2015
Downscaled (bias-corrected) daily temperature data (150 simulations for 10 years) based on the BCC-CSM1.1 CMIP5 model. Seville station Spain.
Morin, Efrat, Zidon, Royi, Morin, Shai, Efrat Morin (3296838), Shai Morin (477123), Royi Zidon (3296841), Hirotsugu Tsueda (3296844), Tsueda, Hirotsugu   +7 more
core   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source